DeutschNewstral
Article
WRAL on 2021-11-12 23:22
Biogen's Alzheimer's drug cited as Medicare premium jumps by $21.60
Related news
Alzheimer’s drug cited as Medicare premium jumps by $21.60Seattle Times
Alzheimer's drug cited as Medicare premium jumps by $21.60 - Fri, 12 Nov 2021 PSTThe Spokesman-Review
Alzheimer’s drug cited as Medicare premium jumps by $21.60 monthlypressherald.com
Medicare severely restricts Biogen's Alzheimer's drug coveragebizjournals.com- BMedicare Will Limit Coverage of Biogen's Alzheimer's Drug2 min readbarrons.com
- Biogen's Alzheimer's drug wins FDA approvalbizjournals.com
- BThe $56,000 Price of Biogen's Alzheimer's Drug Could Backfire4 minbarrons.com
- Biogen's other Alzheimer's drug fails in late-stage trialbizjournals.com
- Biogen's CEO made $17.7M last year despite Alzheimer's drug woesbizjournals.com
- How RTP plays critical role for Biogen's blockbuster Alzheimer's drugbizjournals.com
- After Biogen's big Alzheimer's drug data reveal, observers remain dividedbizjournals.com
FDA approval of Biogen's Alzheimer's drug leaves some 'disappointed'Fox News